A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.
Clinical trial NCT04084197 · COMPLETED
Trial details
- NCT number
- NCT04084197
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2018-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.